St. Jude (STJ) Receives FDA Approval for Unify Quadra CRT-D

St. Jude Medical, Inc. (NYSE: STJ), has received U.S. Food and Drug Administration (FDA) approval of its Unify Quadra cardiac resynchronization therapy defibrillator (CRT-D) and Quartet® Left Ventricular Quadripolar Pacing Lead. The company will begin shipping the products to its sales force to begin providing to customers immediately.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Korro Bio files ethics submission for urea cycle disorder drug trial
• Hyve Solutions opens two Nevada manufacturing campuses, adding 3,000 jobs
• Backblaze prices upsized $175M convertible notes due 2031